ipscell.com
WSJ editorial on issue of stem cells as drugs misses the boat - The Niche
Today I discuss an editorial piece in the WSJ about the recent court ruling giving the FDA authority to regulate stem cells as drugs.
Professor Paul Knoepfler, Ph.D.
